Risk Assessment Report – 16 September 2020
Risk Assessment Report – 16 September 2020
Rapid Risk Assessment
September 16, 2020
Risk Assessment Report – 16 September 2020
Time Period Covered September 16, 2020 - September 16, 2020
- Worldwide, there have been over 29.6 million cases and more than 936,000 deaths attributed to COVID-19. India's total coronavirus cases passed 5 million on Wednesday (September 16), health ministry data showed, as the pandemic extends its grip on the vast country at an ever-faster rate. With its latest 1 million cases recorded in just 11 days, a world record, India now has 5.02 million COVID-19 cases.
- Japan said on Tuesday (September 15) it has committed 17.2 billion yen (US$165 million) in funds for its participation in the World Health Organization's COVID-19 vaccine programme. The programme, known as COVAX, is aimed at helping buy and fairly distribute vaccination shots against the novel coronavirus around the world. But some countries which have secured their own supplies through bilateral deals, including the United States, have said they will not join. The funds are part of a 1.64 trillion yen reserve intended to bolster the government's response to the virus. Japan has also pursued independent arrangements with global pharmaceutical companies to secure vaccines, with the government pledging to have enough supply for the whole population by the first half of 2021. Meanwhile, South Korea will said it will secure early supply of the COVID-19 vaccines for 30 million people, or 60% of its population. South Korea will purchase 20 million doses of vaccines from the COVAX scheme, available for 10 million people, and 40 million doses from private drug makers, the health authorities said in a statement. The government has prepared 172 billion won (US$146 million) to pay for vaccines, including US$70 million for the 20 million doses from the COVAX facility.
- The Philippines Health Ministry said on Wednesday (September 16) that the government continues to negotiate supply deals with a wide range of COVID19 vaccine makers. The Philippines has joined a World Health Organization-led vaccine trials and allocation plan and is promoting itself as a site for pharma firms' phase 3 trials.
Risk Assessment Report – 16 September 2020